Protalix BioTherapeutics, Inc. (PLX) News
Follow Protalix BioTherapeutics, Inc. (PLX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
HC Wainwright & Co. maintains $12.00 share target for Protalix BioTherapeutics
HC Wainwright & Co. maintained a $12.00-per-share price target for Protalix BioTherapeutics, per Benzinga ratings actions.
EQUITY | Sep 09, 2026, 02:55 PM UTC
L
PLX - Protalix BioTherapeutics to Participate in Upcoming September 2026 Investor Conferences
PLX - Protalix BioTherapeutics to Participate in Upcoming September 2026 Investor Conferences
EQUITY | Sep 08, 2026, 10:45 AM UTC
L
PLX Reports Q2 2026 Financial Results
Protalix BioTherapeutics reports second quarter 2026 financial and business results
EARNINGS | Aug 12, 2026, 10:50 AM UTC
L
PLX PLX PLX - Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026 - Click For
PLX PLX PLX - Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026
EARNINGS | Aug 05, 2026, 10:50 AM UTC